Vir Biotechnology, Inc. Earnings Per Share, Basic and Diluted
Vir Biotechnology, Inc. (VIR) reported Earnings Per Share, Basic and Diluted of -$1.32 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-06
- Vir Biotechnology, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$1.32.
- Vir Biotechnology, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.67.
- Vir Biotechnology, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.27.
- Vir Biotechnology, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.71.
- Vir Biotechnology, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.51.
- Vir Biotechnology, Inc. earnings per share, basic and diluted for fiscal 2019 was -$5.76.
- Vir Biotechnology, Inc. earnings per share, basic and diluted for fiscal 2018 was -$15.12.
- Vir Biotechnology, Inc. earnings per share, basic and diluted for fiscal 2017 was -$32.45.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$1.32 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | -$2.51 10-K · filed 2021-02-25 | |||
| 2020-09-30 | -$0.67 10-Q · filed 2020-11-10 | -$1.66 10-Q · filed 2020-11-10 | ||
| 2020-06-30 | -$0.27 10-Q · filed 2020-08-11 | -$0.97 10-Q · filed 2020-08-11 | ||
| 2020-03-31 | -$0.71 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | -$5.76 10-K · filed 2021-02-25 | |||
| 2019-09-30 | -$4.60 10-Q · filed 2020-11-10 | -$11.53 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | -$3.64 10-Q · filed 2020-08-11 | -$6.83 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | -$3.19 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | -$3.05 10-K · filed 2020-03-26 | -$15.12 10-K · filed 2021-02-25 | ||
| 2018-09-30 | -$4.16 10-K · filed 2020-03-26 | -$12.20 10-Q · filed 2019-11-19 | ||
| 2018-06-30 | -$3.35 10-K · filed 2020-03-26 | |||
| 2018-03-31 | -$4.76 10-K · filed 2020-03-26 | |||
| 2017-12-31 | -$32.45 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |